Acute intermittent porphyria (AIP) attacks triggered by surgery can easily be confused with typical postoperative complications, a case report…
Articles by Lindsey Shapiro, PhD
A combination of skin and liver problems in a young person should prompt doctors to suspect erythropoietic protoporphyria (EPP),…
People with genetic mutations that cause acute hepatic porphyria (AHP) who have never experienced acute disease attacks are still…
A European Medicines Agency (EMA) committee has recommended that Scenesse (afamelanotide) be designated an orphan drug for the…
The case of a young woman with recurrent abdominal pain who was diagnosed with acute intermittent porphyria (AIP) underscores…
The BEACON and AURORA Phase 2 clinical trials testing the investigational oral therapy bitopertin in people with erythropoietic porphyrias…
A man with erythropoietic protoporphyria (EPP) and severe liver disease successfully underwent a rare, live-donor liver transplant with his…
Clinuvel has been awarded a five-year contract with the U.S. Department of Veterans Affairs (VA) to supply Scenesse…
Years of monthly treatment with Givlaari (givosiran) continued to be associated with sustained reductions in acute disease attacks and…
A recent case report highlights the extremely rare occurrence of two diseases — acute intermittent porphyria (AIP) and…